Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,366.50
Bid: 1,360.50
Ask: 1,361.50
Change: 61.00 (4.67%)
Spread: 1.00 (0.074%)
Open: 1,318.50
High: 1,366.50
Low: 1,309.50
Prev. Close: 1,305.50
PSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 Trading Statement

25 Apr 2024 07:00

RNS Number : 9243L
Persimmon PLC
25 April 2024
 

 

25 April 2024

Q1 Trading Statement

 

Persimmon Plc is today providing an update on trading for the period from 1 January 2024 to 31 March 2024, ahead of its Annual General Meeting ("AGM") which is being held at 11.00am today in York.

 

Dean Finch, Group Chief Executive, commented:

 

"Persimmon has had a good start to the year and is on track to deliver growth in completions to between 10,000-10,500 for the full year. Our first quarter performance was in line with expectations, and we saw an improvement in sales rates alongside firm pricing. Trading over recent weeks has been encouraging with robust visitor numbers and enquiries, giving us confidence for the remainder of the year. Overall, our private forward order book is up 18% on the prior year with the embedded private average selling price ahead of the position at the start of the year. We are making good progress in expanding our outlet network and we will continue to position the business for success, maintaining our focus on quality and customer service, and converting our land holdings into active developments."

 

Q1 Highlights

 

Q1 2024

Q1 2023

New home completions

1,027

1,136

Net private sales per outlet1

0.66

0.62

Current forward sales position2

£1.75bn

£1.69bn

Of which private forward sales2

£1.14bn

£0.97bn

Land holdings (plots owned and under control)

c.82,500

c.86,400

 

1Net private sales per outlet of 0.61 excluding bulk sales (Q1 2023: 0.58)

2Excluding completions in Q1 and as at 25 April 2024 for 2024 figure, as at 26 April 2023 for 2023 figure.

 

Trading

The Group traded in line with expectations during the first quarter delivering a total of 1,027 homes (Q1 2023: 1,136 homes). This included 852 private homes (Q1 2023: 902 homes) and 175 Partnership homes (Q1 2023: 234 homes).

 

The net private sales rate per outlet was up 6% in the first quarter at 0.66, or 0.61 excluding bulk sales. Customer interest remains good, and our marketing campaigns continue to generate healthy traffic to sites and online, despite ongoing affordability constraints.

 

Overall pricing on reservations held firm in the first quarter, with incentives currently running around 4-5% on average. Our private forward sales position has increased to £1.14bn with a private average selling price of c.£283,000 up 6% since the position at the start of the year (31 December 2023: c.£266,100).

 

Land spend in the first quarter was £145m (Q1 2023: £173m) of which £96m related to the settlement of land creditors (Q1 2023: £131m). Our owned and under control land holdings stood at c.82,500 plots at 31 March 2024 (31 March 2023: c.86,400 plots) and the embedded margin of the land portfolio remains industry-leading.

 

Outlook

We are encouraged by the level of visitors to our sites and are making good progress in expanding our outlet network. We opened 28 gross outlets in the first quarter ending the period with 263 outlets, up 2% on the position at the start of the year. A further c.30 gross outlets are planned to open by the end of June as part of our ambition to build back to pre-Covid outlet levels over the medium term.

As previously noted, first-half performance will be subject to embedded build cost inflation and lower average selling prices, as reflected in the forward order book at the start of the year. This trend is expected to reverse in the second half, given the increase in the average selling price in the current forward order book and broadly neutral build cost inflation since the start of the year. We continue to expect growth in full year 2024 completions to between 10,000 and 10,500 completions with an operating margin in line with the prior year.

 

For further information please contact:

Victoria Prior, Group IR Director

Anthony Vigor, Group Director of Strategic Partnerships and External Affairs

Olivia Peters

Teneo

Persimmon Plc 

persimmon@teneo.com

Tel: +44 (0) 1904 642199

Tel: +44 (0) 7902 771 008

 

 

Appendices:

1. Quarterly performance

 

Q1 2024

Q1 2023

Variance

Completions (homes)

1,027

1,136

-10%

Private (homes)

852

902

-6%

Partnership (homes)

175

234

-25%

Net private sales rate1

0.66

0.62

+6%

FTB % (private completions)

28%

38%

-10ppts

 

1Net private sales per outlet of 0.61 excluding bulk sales (Q1 2023: 0.58)

 

 

25 April 2024

26 April 2023

Variance

2. Forward sales1

Value

Homes

Value

Homes

Value

Homes

Private

£1.14bn

4,030

£0.97bn

3,496

+18%

+15%

Partnership

£0.61bn

3,762

£0.72bn

4,715

-16%

-20%

Total

£1.75bn

7,792

£1.69bn

8,211

+4%

-5%

 

1Excluding completions in Q1 and as at 25 April 2024 for 2024 figure, as at 26 April 2023 for 2023 figure.

 

Cautionary statements

Some of the information in this document may contain projections or other forward-looking statements regarding future events or the future financial performance of Persimmon Plc and its subsidiaries (the Group). You can identify forward-looking statements by the terms such as "expect", "believe", "anticipate", "estimate", "intend", "will", "could", "may" or "might", the negative of such terms or similar expressions. Persimmon Plc (the Company) wishes to caution you that these statements are only predictions and that actual events or results may differ materially and as such undue reliance should not be placed on these statements. The Company does not intend to update these statements to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events. Many factors could cause the actual results to differ materially from those contained in projections or forward-looking statements of the Group, including among others, general economic conditions, the competitive environment as well as many other risks specifically related to the Group and its operations. Past performance of the Group cannot be relied on as a guide to future performance.

 

Please see the most recent Annual Report and Accounts of Persimmon plc and other disclosures through the Regulatory News Service ("RNS") for further details of risks, uncertainties and other factors relevant to the business and its securities.

 

The information in this trading statement is unaudited.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFRSTISFIS
Date   Source Headline
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company
8th Nov 20237:00 amRNSAppointment of Chief Financial Officer
7th Nov 20237:00 amRNSQ3 Trading Statement
3rd Nov 20231:15 pmRNSHolding(s) in Company
1st Sep 20231:15 pmRNSTotal Voting Rights
10th Aug 20237:04 amRNSHalf Year Results
27th Jul 202310:13 amRNSDirectorate Change
10th Jul 20239:27 amRNSDirector Declaration
3rd Jul 20232:46 pmRNSTotal Voting Rights
1st Jun 20234:38 pmRNSTR-1: Notification of major holdings
1st Jun 20231:07 pmRNSBlock listing Interim Review
1st Jun 202311:06 amRNSTotal Voting Rights
3rd May 20235:00 pmRNSHolding(s) in Company
3rd May 20234:12 pmRNSDirector/PDMR Shareholding
2nd May 202311:13 amRNSTotal Voting Rights
26th Apr 20234:32 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 Trading Statement
3rd Apr 20234:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:05 pmRNSTotal Voting Rights
27th Mar 20233:44 pmRNSDirector/PDMR Shareholding
22nd Mar 20233:00 pmRNSAnnual Report 2022 and Notice of AGM 2023
13th Mar 20231:57 pmRNSDirectorate Change
13th Mar 202312:19 pmRNSUK Government Self Remediation Contract Signed
7th Mar 20235:33 pmRNSHolding(s) in Company
7th Mar 20237:04 amRNSDirector Declaration
6th Mar 20235:02 pmRNSHolding(s) in Company
1st Mar 20237:00 amRNSFull Year Results
12th Jan 20237:00 amRNSTrading Statement
1st Dec 20225:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Dec 20225:25 pmRNSVoting Rights and Capital
8th Nov 20227:00 amRNSTrading Statement
1st Nov 20221:00 pmRNSTotal Voting Rights
1st Nov 20229:24 amRNSHolding(s) in Company
10th Oct 20222:24 pmRNSDirector/PDMR Shareholding
5th Oct 202210:26 amRNSHolding(s) in Company
4th Oct 20223:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.